Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 1/20 | 0.51 |
| ▸ | ADH1C | P00326 | 1/20 | 0.51 |
| ▸ | ADH1A | P07327 | 1/20 | 0.51 |
| ▸ | ADH4 | P08319 | 1/20 | 0.51 |
| ▸ | ADH7 | P40394 | 1/20 | 0.51 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 1/20 | 0.44 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.44 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7153248 | 0.78 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL8005773 | 0.78 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL3179420 | 0.78 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7156258 | 0.78 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL28318789 | 0.77 | ADH1B (0.56) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL20366018 | 0.77 | ADH1B (0.56) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL9014767 | 0.77 | ADH1B (0.55) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL11681362 | 0.76 | GPR84 (0.48) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL9731775 | 0.75 | MEN1 (0.63) | GPR84FFAR1FFAR4FAAHMEN1 | |
| SCHEMBL3188855 | 0.75 | MEN1 (0.63) | GPR84FFAR1FFAR4FAAHMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8207370-B2 | Process for producing optically active beta-hydroxy-alpha-aminocarboxylic acid ester | KANEKA CORPORATION (JP) | 2012-06-26 | — | — | US | disclosed |
| US-20100022795-A1 | Process for producing optically active beta-hydroxy-alpha-aminocarboxylic acid ester | KANEKA CORPORATION (JP) | 2010-01-28 | — | — | US | disclosed |
| EP-2067769-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE BETA-HYDROXY-ALPHA-AMINOCARBOXYLIC ACID ESTER | Kaneka Corporation (JP) | 2009-06-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022795-A1 | Process for producing optically active beta-hydroxy-alpha-aminocarboxylic acid ester | AADAT, ALAD, ALDH7A1 | ADH1B 557/4885ADH1C 573/4885ADH1A 445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.